Beta3-containing gamma-aminobutyric acidA receptors are not major targets for the amnesic and immobilizing actions of isoflurane.
Mice bearing an N265M point mutation in the gamma-aminobutyric acid (GABA)(A) receptor beta3 subunit resist various anesthetic effects of propofol and etomidate. They also require a 16% larger concentration of enflurane and a 21% larger concentration of halothane to abolish the withdrawal reflex than do wild-type mice. Using a Pavlovian test, we measured whether this mutation increased the concentration of isoflurane required to impair learning and memory relative to wild-type mice. We found that the concentration was not significantly increased. We also measured MAC (the minimum alveolar concentration required to eliminate movement in response to noxious stimulation in 50% of subjects). Isoflurane MAC for mutant mice (1.93% +/- 0.0.03%; mean +/- se; n = 14) was 17.0% larger than MAC for wild-type mice (1.65 +/- 0.04; n = 14; P < 0.001). Similarly, the cyclopropane MAC for mutant mice (27.6% +/- 0.55%; n = 16) was 13.6% larger than MAC for wild-type mice (24.3 +/- 0.46; n = 8; P < 0.01). The increase in MAC for cyclopropane was unexpected, because published reports find only minimal actions at alpha1beta2gamma2 GABA(A) receptors whereas isoflurane provides a large enhancement. Consistent with previous work on alpha1beta2gamma2 GABA(A) receptors, we found in Xenopus oocytes that 5 MAC cyclopropane enhanced the effect of GABA on alpha1beta2gamma2 GABA(A) receptors by only 76%, and by a nearly identical enhancement in alpha1beta3gamma2, and alpha6beta3gamma2 receptors. In contrast, a much smaller concentration of isoflurane (1 MAC) produced a 160% to 310% enhancement in these receptors. If, relative to isoflurane, cyclopropane minimally increases GABA-induced chloride currents at any GABA(A) receptor subtype, the present data for MAC are consistent with the notion that GABA(A) receptors do not mediate the immobility produced by inhaled anesthetics.


CONCLUSIONS
The results of the present study indicate that beta3-containing gamma-aminobutyric acidA receptors do not mediate the amnesia produced by isoflurane and do not mediate, or only partially mediate, the immobility produced by inhaled anesthetics.
Liao
Mark
M
*Department of Anesthesia and Perioperative Care, University of California, San Francisco, California; †Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland; and ‡Waggoner Center for Alcohol and Addiction Research, University of Texas, Austin, Texas.
Sonner
James M
JM
Jurd
Rachel
R
Rudolph
Uwe
U
Borghese
Cecilia M
CM
Harris
R Adron
RA
Laster
Michael J
MJ
Eger
Edmond I
EI
D000161:Acoustic Stimulation; D000647:Amnesia / Q000139:chemically induced*; D000777:Anesthetics / Q000494:pharmacology; D018685:Anesthetics, Inhalation / Q000494:pharmacology*; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D003214:Conditioning, Classical / Q000187:drug effects; D003521:Cyclopropanes / Q000494:pharmacology; D018076:DNA, Complementary / Q000096:biosynthesis / Q000235:genetics; D004305:Dose-Response Relationship, Drug; D005260:Female; D007530:Isoflurane / Q000494:pharmacology*; D007858:Learning / Q000187:drug effects; D008297:Male; D008568:Memory / Q000187:drug effects; D051379:Mice; D018345:Mice, Knockout; D009068:Movement / Q000187:drug effects; D011650:Pulmonary Alveoli / Q000378:metabolism; D011963:Receptors, GABA-A / Q000187:drug effects* / Q000235:genetics
D000777:Anesthetics; D018685:Anesthetics, Inhalation; D003521:Cyclopropanes; D018076:DNA, Complementary; C546270:Gabrb3 protein, mouse; D011963:Receptors, GABA-A; C030797:cyclopropane; D007530:Isoflurane